Werbung
Werbung

INDP

INDP logo

Indaptus Therapeutics, Inc. Common Stock

3.13
USD
Gesponsert
+0.13
+4.30%
09. Jan., 15:59 UTC -5
Geschlossen
exchange

Nach-Markt

3.10

-0.02
-0.77%

INDP Ergebnisberichte

Positives Überraschungsverhältnis

INDP übertreffen die 23 der letzten 39Schätzungen.

59%

Nächster Bericht

Datum des nächsten Berichts
10. März 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/
-$4.44
Implizierte Änderung von Q3 25 (Revenue/ EPS)
--
/
+48.99%
Implizierte Änderung von Q4 24 (Revenue/ EPS)
--
/
-58.27%

Indaptus Therapeutics, Inc. Common Stock earnings per share and revenue

On 12. Nov. 2025, INDP reported earnings of -2.98 USD per share (EPS) for Q3 25, beating the estimate of -4.25 USD, resulting in a 29.94% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +6.25% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 3 analysts forecast an EPS of -4.44 USD, with revenue projected to reach -- USD, implying an increase of 48.99% EPS, and increase of 0.00% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Citius Pharmaceuticals Inc. Common
Report Date
26. Dez. 2025 For Q4 25
Estimate
-$0.49
Aktuell
-
Überraschung
-
FAQ
For Q3 2025, Indaptus Therapeutics, Inc. Common Stock reported EPS of -$2.98, beating estimates by 29.94%, and revenue of $0.00, 0% as expectations.
The stock price moved up 6.25%, changed from $2.72 before the earnings release to $2.89 the day after.
The next earning report is scheduled for 10. März 2026.
Based on 3 analysts, Indaptus Therapeutics, Inc. Common Stock is expected to report EPS of -$4.44 and revenue of -- for Q4 2025.
Scheck FXEmpire's Earnings Calendar for today's list of reporting companies.
Werbung